Acute psilocybin enhances cognitive flexibility in rats.

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Psilocybin shows promise in treating depression and anxiety, often alongside psychotherapy.
• The neural mechanisms underlying psilocybin's clinical benefits require further investigation beyond traditional models.
• Cognitive flexibility may be a key mechanism through which psilocybin enhances therapeutic interventions.

Purpose of the Study:

• To investigate the effect of psilocybin on cognitive flexibility in a rodent model.
• To explore the specific serotonin receptor subtypes involved in psilocybin's cognitive effects.
• To determine if psilocybin's impact on cognitive flexibility is a generalizable effect of serotonergic psychedelics.

Main Methods:

• Rats were tested on a set-shifting task to assess cognitive flexibility.
• The effects of psilocybin were examined in both male and female rats.
• Pharmacological manipulations using serotonin (5HT) 2A and 5HT2C receptor antagonists, as well as the psychedelic drug DOI, were employed.

Main Results:

• Acute psilocybin administration significantly improved cognitive flexibility in rats, characterized by enhanced strategy switching.
• Psilocybin's pro-flexibility effects were blocked by a 5HT2A antagonist but not a 5HT2C antagonist.
• The psychedelic drug DOI impaired cognitive flexibility, indicating that psilocybin's effect is not universal to all serotonergic psychedelics.

Conclusions:

• Acute psilocybin enhances cognitive flexibility, providing a potential neural basis for its clinical efficacy in mental health.
• The serotonin 2A receptor plays a crucial role in mediating psilocybin's effects on cognitive flexibility.
• This study establishes a valuable behavioral model for exploring the neurobiological underpinnings of psilocybin's therapeutic actions.